check_circleStudy Completed

Diabetes Mellitus, Type 1

Bayer Identifier:

Trial_0634

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Efficacy and tolerability of acarbose (BAY g 5421) versus placebo in diabetic children receiving conventional insulin treatment

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

6 - 16 Years
  • -

  • -

Trial summary

Enrollment Goal
31
Trial Dates
May 1991 - March 1992
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Acarbose (Precose/Glucobay, BAYG5421)
Accepts Healthy Volunteer
N/A

Trial design

Clinical study to investigate the efficacy and tolerability of acarbose (BAY g 5421) versus placebo in diabetic children receiving conventional insulin treatment, with particular regard to variations in the blood glucose level
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.